From USD 2.35 billion in 2016, the HIV diagnostic market is expected to grow at a CAGR of 10.5 percent to USD 3.88 billion by 2021. The market is predicted to develop due to factors such as the rising global prevalence of HIV/AIDS, the rising number of blood transfusions and blood donations, the benefits provided by point-of-care tools and kits, and increased government initiatives. The study's base year was 2015, and the projection was made for the years 2016 through 2021.
To estimate and validate the size of the worldwide HIV diagnosis market, as well as the size of numerous other dependent submarkets, top-down and bottom-up methodologies were utilised. Through percentage splits from secondary and primary research, the overall market size was used in the top-down approach to estimate the sizes of other individual markets (specified in the market segmentation-by-products and region). To validate the market segment revenues obtained, the bottom-up approach was also used (where available) for data extracted from secondary research.
Publications from government sources, such as white papers; articles from recognised authors; gold and silver standard websites, directories, and databases; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and economic journals are among the secondary sources used in this research study. To acquire and verify crucial information, primary sources such as specialists from linked industries and suppliers were questioned.
Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo-Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc. (US), Alere Inc. (US), and Bio-Rad Laboratories (US) are the major players in the HIV diagnosis market (US).
This study gives you an inside look at the global HIV diagnosis industry. It includes useful information about the HIV diagnostic market's products, test types, and geographies. This study also includes a regional analysis of these sectors. Leading market participants are profiled in order to learn more about their device offerings and the methods they use to stay competitive.
The information provided above will aid the buyer in comprehending market dynamics. Furthermore, the forecasts in the research will help businesses better understand industry trends and position themselves to take advantage of development prospects.
AIDS is a huge public health concern, with a dramatically rising prevalence rate over the last two decades. As the prevalence of HIV rises, so does the number of people living with AIDS. As a result, there is a greater demand for better HIV diagnostics.
According to the World Health Organization (WHO), over 36 million persons were diagnosed with HIV worldwide in 2016, with 2.1 million cases of new HIV infections reported. In 2015, 1.1 million people died worldwide from HIV-related causes. According to the CDC, more than 1.2 million persons in the United States were infected with HIV in 2015, with about 19 percent of those infected unaware of their status. According to the CATIE, Canada's HIV source, 75,500 Canadians were diagnosed with HIV in 2014, and HIV incidence has increased by 9.7% since 2011. According to the Robert Koch Institute, there were 84,700 HIV-positive people in Germany in 2016, with over 3,200 new infections.
Comments
Post a Comment